Exposure to air pollutants (PM2.5 and PM10) is associated with an increased risk of persistent long-COVID symptoms, partly due to its impact on the severity of the acute infection.
Intas Pharmaceuticals’ Indian facility hit with FDA warning letter, placed on import alert
Intas Pharmaceuticals has been issued another warning letter after FDA inspectors uncovered manipulated records and contamination issues at its facility in Gujarat, India following a